OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer
Chengzhi Wang, Xin Li, Lijuan Zhang, et al.
International Immunopharmacology (2021) Vol. 97, pp. 107822-107822
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Arefeh Zabeti Touchaei, Sogand Vahidi
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 32

miRNAs in pancreatic cancer progression and metastasis
Ellie T. Y. Mok, Jessica L. Chitty, Thomas R. Cox
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 3, pp. 163-186
Open Access | Times Cited: 26

MicroRNAs in Pancreatic Cancer: Advances in Biomarker Discovery and Therapeutic Implications
Roland Madadjim, Thuy An, Juan Cui
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3914-3914
Open Access | Times Cited: 12

Relationship between miRNA and ferroptosis in tumors
Shang‐Ming Dai, Feng‐Jiao Li, Hui‐Zhi Long, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34

Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression
James A. McCubrey, Li V. Yang, Stephen L. Abrams, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2155-2155
Open Access | Times Cited: 30

Inhibition of miR-194-5p avoids DUSP9 downregulation thus limiting sepsis-induced cardiomyopathy
Jie Wang, Ting Wei, Wei Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5

Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma
John G. Yuen, Ga‐Ram Hwang, Andrew Fesler, et al.
Deleted Journal (2024) Vol. 32, Iss. 1, pp. 200769-200769
Open Access | Times Cited: 4

Programmed cell death-ligand 2: new insights in cancer
Yukang Yang, Yan Xia, Xueqi Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

Extracellular vesicles and the “six Rs” in radiotherapy
Isabel Ripoll-Viladomiu, Adriele Prina‐Mello, Dania Movia, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102799-102799
Open Access | Times Cited: 4

Ultrasound nanobubble-based combinational strategies of loaded miR-107-3p and CD133 Ab for anti-PD-L1 and anti-hepatocellular cancer stem cells
C Zhang, Yezi Chen, Jiaxuan Han, et al.
International Journal of Pharmaceutics (2025), pp. 125140-125140
Closed Access

HCG18 Promotes Cell Proliferation and Stemness in Cholangiocarcinoma via the miR-194-5p/KRT18/MAPK Signaling
Guodong Tian, Lu Zuo, Jie Li, et al.
Biochemical Genetics (2025)
Closed Access

Identifying microRNAs associated with tumor immunotherapy response using an interpretable machine learning model
Dong-Yeon Nam, Je‐Keun Rhee
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer
Ф. М. Кипкеева, Tatyana Muzaffarova, А. А. Коротаева, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9324-9324
Open Access | Times Cited: 13

Flavonoids as modulators of miRNA expression in pancreatic cancer: Pathways, Mechanisms, And Therapeutic Potential
Helen Helen, Mega Carensia Gunawan, Princella Halim, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117347-117347
Open Access | Times Cited: 2

Unraveling the interplay of CD8 + T cells and microRNA signaling in cancer: implications for immune dysfunction and therapeutic approaches
Arefeh Zabeti Touchaei, Sogand Vahidi
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2

The miR-199a-5p/PD-L1 axis regulates cell proliferation, migration and invasion in follicular thyroid carcinoma
Jianguang Lin, Yanru Qiu, Xueqin Zheng, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10

Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer
A.S. Pal, Anushka Ojha, Jingfang Ju
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17523-17523
Open Access | Times Cited: 6

Ezrin and Radixin Differentially Modulate Cell Surface Expression of Programmed Death Ligand-1 in Human Pancreatic Ductal Adenocarcinoma KP-2 Cells
Takuro Kobori, Rina Doukuni, Honami Ishikawa, et al.
Immuno (2022) Vol. 2, Iss. 1, pp. 68-84
Open Access | Times Cited: 8

Long Non-Coding RNAs as Epigenetic Regulators of Immune Checkpoints in Cancer Immunity
Wiam Saadi, Ahlam Fatmi, Federico V. Pallardó, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 184-184
Open Access | Times Cited: 8

Scaffold-mediated switching of lymphoma metabolism in culture
Rachana Bhatt, Dashnamoorthy Ravi, Andrew M. Evens, et al.
Cancer & Metabolism (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 7

The potential role of exosomal miRNAs and membrane proteins in acute HIV-infected people
Xin Li, Wenjing Wang, Jing Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6

Identification of tumor-suppressive miRNAs that target amino acid transporter LAT1 and exhibit anti-proliferative effects on cholangiocarcinoma cells
Xingming Liu, Kou Nishikubo, Ryuichi Ohgaki, et al.
Journal of Pharmacological Sciences (2024) Vol. 154, Iss. 4, pp. 301-311
Open Access

Page 1 - Next Page

Scroll to top